E Fund Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
+589,020
New +$1.2M 0.03% 191
2023
Q1
Sell
-62,962
Closed -$263K 345
2022
Q4
$263K Sell
62,962
-39,195
-38% -$148K 0.02% 248
2022
Q3
$410K Sell
102,157
-310,000
-75% -$2.35M 0.04% 177
2022
Q2
$4.66M Sell
412,157
-22,666
-5% -$272K 0.42% 36
2022
Q1
$7.01M Buy
434,823
+46,050
+12% +$1.18M 0.23% 26
2021
Q4
$18.4M Buy
388,773
+45,126
+13% +$2.71M 0.65% 14
2021
Q3
$24.9M Buy
+343,647
New +$24.9M 1.04% 13
2021
Q1
$17.2M Buy
+355,865
New +$19.3M 1.42% 17

Other funds holding NBP

E Fund Management's NBP Position: Q2 2026 in Review

E Fund Management opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 589,020 shares worth $1.15M. The stake represents 0.03% of the portfolio and ranks #191 among its holdings. This is a return to the name: E Fund Management previously reported a position in NBP as recently as Q4 2022.

E Fund Management first reported a position in NBP in Q1 2021 and has held it in 8 quarters since. The position peaked at $24.9M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • E Fund Management held 589,020 shares of NovaBridge Biosciences American Depositary Shares worth $1.15M as of Q2 2026.
  • NovaBridge Biosciences American Depositary Shares was a new E Fund Management position in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up 0.03% of E Fund Management's portfolio in Q2 2026, its #191 holding.
  • E Fund Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and has held it in 8 quarters since.
  • E Fund Management's NovaBridge Biosciences American Depositary Shares position peaked at $24.9M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.